Invention Grant
- Patent Title: Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension
-
Application No.: US14511044Application Date: 2014-10-09
-
Publication No.: US09751876B2Publication Date: 2017-09-05
- Inventor: Ian Bruce , Sylvie Chamoin , Stephen Paul Collingwood , Pascal Furet , Vikki Furminger , Diana Janus , Sarah Lewis , Jon Christopher Loren , Valentina Molteni , Alex Michael Saunders , Duncan Shaw , Lilya Sviridenko , Christopher Thomson , Ryan West , Vince Yeh
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Shawn D. Britt
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K31/444 ; A61K31/4545 ; A61K31/496 ; A61K31/5377 ; A61K45/06 ; A61K31/4745
Abstract:
Bicyclic heterocyclic derivatives of formula I useful in inhibiting PDGF receptor mediated biological activity. wherein A is and R1, R1a, R2, R3, R4, R5, R6 and X are as defined herein.
Public/Granted literature
- US20150025059A1 BICYCLIC HETEROCYCLE DERIVATIVES FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION Public/Granted day:2015-01-22
Information query
